Position in BIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,761,003
-$1,838,637 QoQ
Shares Held
111,580
-2.3% QoQ
Ownership
0.417%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 397 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026NORGES BANK holds $8,506,007,933 across 26 Medical Devices names. BIO ranks #14 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
23,354,911 | $2,119,224,624 | |
| 2 | SYK |
Stryker Corp
|
4,892,615 | $1,540,390,906 | |
| 3 | MDT |
Medtronic plc
|
16,551,016 | $1,294,785,981 | |
| 4 | BSX |
Boston Scientific Corp
|
21,170,029 | $903,536,837 | |
| 5 | EW |
Edwards Lifesciences Corp
|
8,373,783 | $757,492,410 | |
| 6 | DXCM |
Dexcom Inc
|
6,868,090 | $462,565,861 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
5,823,524 | $372,763,771 | |
| 8 | STE |
STERIS plc
|
1,192,173 | $251,035,868 |
All Filings in BIO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,761,003 | 111,580 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $34,599,640 | 114,194 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $30,987,418 | 128,408 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,169,261 | 156,714 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $41,643,898 | 126,766 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $65,083,170 | 194,522 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $61,877,713 | 226,567 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $81,212,351 | 234,806 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $73,142,011 | 226,523 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $81,460,630 | 227,258 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $86,158,052 | 227,258 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $108,416,596 | 226,330 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $91,442,698 | 217,467 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $84,247,680 | 201,965 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $97,882,785 | 197,743 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $117,882,349 | 209,297 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $161,152,503 | 213,286 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $154,307,217 | 206,860 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $134,290,008 | 208,431 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $120,229,571 | 210,497 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $119,608,795 | 205,182 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $114,439,336 | 222,014 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $97,288,871 | 215,484 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $73,242,150 | 208,929 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||